Aristotle University Of Thessaloniki (AUTH)
In vivo πειραματική μελέτη της οστεοεπαγωγικής ικανότητας του πεπτιδίου 3 της οστικής μορφογενετικής πρωτεΐνης-2
Abstract
dc:descriptionAim and scope: Despite bone’s considerable potential for regeneration and remodelling, in everyday clinical practice, Orthopaedics have to face fracture non-union and large bone defects needing grafting much more common than previously. Aim of the present Thesis is to confirm in vivo the osteoinduction and safety of a novel and promising growth factor, called Peptide 3, which is a 10-mer peptide derived from BMP-2, as well as to provide evidence of non-inferiority in comparison with BMP-2 itself. Moreover, a series of novel gelatin sponges have been studied aiming to provide a new combination that could be used as a future bone graft. Materials and Methods: 27 male adult white Wistar rats have been used in the present Thesis, in an ectopic ossification model. Pilot studies were performed initially to check and confirm the materials used and various factors during the experimental process. Best procedure was verified. Main part of the in vivo experiments included a comparison of osteoinduction between Peptide 3 and BMP-2 in combination with collagen (Helistat®) and gelatin B sponges (intercalated and not). Last part of the experiments included materials that could be the basis for future research. Regarding the main part of the study, 150μg Peptide 3 or 25μg BMP-2 were combined with Helistat® collagen sponges, Gelatin B 5% sponges and intercalated Gelatin materials, forming eight groups. On day 0, following intra-peritoneal anaesthesia, four intramuscular pockets were created at the dorsum of the rats. Final implants were a combination of sponge and growth factor, as mentioned above. Each rat lived in an individual cage under constant temperature and humidity conditions, followed a fixed light-dark cycle (every 12 hours) and had ad libitum access to standard food and fresh water. After four weeks (day 28), rats were killed by carbon dioxide inhalation, while the final preparations resulting from the removal of the materials were observed under the light microscope after staining with hematoxylin-eosin. A total of 16 factors were studied and recorded, including material remnants, presence of inflammation and cells, neovascularization and fibrosis, presence of osteoid, newly formed ectopic bone tissue and bone marrow. Results: No local or generalized reactions to the materials or any impairment in the healing of the surgical wound were observed. There was one animal loss during the experiments which was caused as a complication of anaesthesia. No statistically significant difference was observed between Peptide 3 and BMP-2 in any of the parameters studied either in their combination with Helistat® or with the Gelatin B 5% sponges. On the contrary, the combination of growth factors (25μg BMP-2 or 150μg Peptide 3) with the Gelatin B 5% sponges showed significantly more newly formed ectopic bone tissue compared to the use of Helistat® (p=0.03 and 0.04 respectively). In addition, the Gelatin B groups showed significantly more residual material elements, while the Peptide 3 and Gelatin combination showed more evidence of inflammation and neovascularization. Finally, the intercalated sponges, whether carrying BMP-2 or Peptide 3, showed significantly more ectopic ossification, neovascularization and the presence of osteoblasts compared to the combination of Helistat® with BMP-2. All ossification variables that could be statistically processed (newly formed bone, presence of osteoblasts, osteoclasts and bone marrow) showed a significant positive correlation with the scaffold used, residual material and neovascularization. Conclusion: The pilot experiments confirmed the safety and osteoinductive properties of Peptide 3, while the main part of the study demonstrated its non-inferiority to BMP-2, at the doses used. In particular, the combination of Peptide 3 with the 5% Gelatin B sponges, and especially the intercalated ones, demonstrated remarkable osteoinductive properties and osteoconductivity. We hope that the above material will constitute an important milestone in the development of Bone Engineering.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzavellas, Anastasios-Nektarios
- Τζαβέλλας, Αναστάσιος-Νεκτάριος
Subjects
dc:subject × 19- Οστική μορφογενετική πρωτείνη - 2
- Μηχανική ιστών
- Σπόγγοι ζελατίνης
- Οστεοεπαγωγή
- Bone morphogenetic protein - 2
- Tissue engineering
- Gelatine sponge
- Osteoinduction
- Βιοϊατρική Μηχανική
- Επιστήμες Μηχανικού και Τεχνολογία
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Medical Engineering
- Engineering and Technology
- Biomedical Engineering
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60148